Concepedia

Yuting Liu

YL

Statistics

Publications

15

Citations

736

H-Index

13

Active since

2015

Affiliations

Biogen (United States)(Current)

Tongji University

Tongji Hospital

Fudan University Shanghai Cancer Center

Yuting Liu is an author at Biogen (United States) specializing in life sciences, pharmacology, and neurodegenerative diseases.

ORCID

Publications per year

2015–2024

15

Publications

15

Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models

Andreas Weihofen, Yuting Liu, Joseph W. Arndt et al. · Neurobiology of Disease · 2018 · 198 citations · Full text

, , +17

Randomized phase I clinical trial of anti–α‐synuclein antibody BIIB054

Laura Fanning, Serena Hung, Aaron Ellenbogen et al. · Movement Disorders · 2019 · 194 citations · Full text

, , +17

The impact of statins therapy on disease activity and inflammatory factor in patients with rheumatoid arthritis: a meta-analysis.

Shunzeng Lv, Yuting Liu, Zhigeng Zou et al. · PubMed · 2015 · 75 citations

, , +15

The Parkinson’s disease-associated gene ITPKB protects against α-synuclein aggregation by regulating ER-to-mitochondria calcium release

Daniel J. Apicco, Evgeny Shlevkov, Catherine L. Nezich et al. · Proceedings of the National Academy of Sciences · 2020 · 63 citations · Full text

, , +17

Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand

D.J. Marcotte, Yuting Liu, Kevin Little et al. · BMC Structural Biology · 2016 · 31 citations · Full text

, , +17

1–5 of 15